Conferences - Results from #8240

#AUA15 - Intelligent percutaneous nephrostomy (PCN) insertion system which can detect the needle’s penetration of lung or intestine: In vitro study - Session Highlights May 17, 2015

#AUA15 - Utilizing more restrictive criteria for obtaining urodynamics in women with multiple sclerosis does not result in more worrisome findings - Session Highlights May 17, 2015

#AUA15 - Intradetrusor botulinum toxin for the management of impaired bladder compliance refractory to anti-cholinergic drugs - Session Highlights May 17, 2015

#AUA15 - Does asymptomatic bacteriuria increase the risk of urosepsis or modify intra-detrusor botulinum toxin A (BoNTA) efficacy? - Session Highlights May 17, 2015

#AUA15 - Results from a multi-institutional, prospective clinical trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry - Session Highlights May 17, 2015

#AUA15 - Examination of copy number alterations in renal cell carcinoma with sarcomatoid features - Session Highlights May 17, 2015

#AUA15 - A multicenter phase 2 study of enzalutamide vs bicalutamide in men with nonmetastatic or metastatic castration-resistant prostate cancer: The STRIVE trial - Session Highlights May 17, 2015

#AUA15 - Use of linear discriminant analysis in a urine-based test for bladder cancer diagnosis - Session Highlights May 17, 2015

#AUA15 - Late Breaking Abstract: Results of enzalutamide versus bicalutamide in metastatic castration-resistant prostate cancer - Session Highlights May 17, 2015

#AUA15 - Hematuria practice patterns in the primary care setting - Session Highlights May 17, 2015

#AUA15 - Epithelial tumor markers (CA 125, CA 19-9, CEA) trends in patients undergoing treatment for invasive bladder cancer - Session Highlights May 17, 2015

#AUA15 - Adiposis is an independent risk-factor for developing high-risk prostate cancer - A prospective study - Session Highlights May 17, 2015

#AUA15 - Oncological outcomes in high-risk prostate cancer after radical prostatectomy: Comparing Gleason 8 versus 9, 10 disease - Session Highlights May 17, 2015

#AUA15 - Clinical stage I renal mass upstaging to pathological T3a disease portends a worse prognosis only when sinus fat invasion is present - Session Highlights May 17, 2015

#AUA15 - Identification of actionable targets in chromophobe renal cell carcinoma detected by multiplatform molecular analysis - Session Highlights May 17, 2015

#AUA15 - The rapid evolution of tissue-based RNA expression assays to improve prostate cancer prognosis and decision making - Session Highlights May 17, 2015

#AUA15 - Personalizing therapy for castration resistant prostate cancer in 2015 - Session Highlights May 17, 2015

#AUA15 - Screening for lethal prostate cancer using PSA and related blood biomarkers - Session Highlights May 17, 2015

#AUA15 - Late Breaking Abstract: Glypican-1 as a biomarker for prostate cancer - Session Highlights May 17, 2015

#AUA15 - Late Breaking Abstract: Validation of a novel non-invasive urine exosome gene expression assay to predict high-grade prostate cancer in patients undergoing initial biopsy with an equivocal PSA - Session Highlights May 17, 2015

Page 413 of 484

email news signup